The approval granted by the US Food and Drug Administration (USFDA) is to manufacture and market Sucralfate Tablets of strength 1 gram, Zydus Lifesciences said in a regulatory filing. The drug will be manufactured at the group's topical manufacturing facility at SEZ, Ahmedabad, it added.
from Top Health News | Latest Health & Healthcare Industry Information and Updates: ET HealthWorld : ETHealthworld.com https://ift.tt/cBfDENg
Home »
Top Health News | Latest Health & Healthcare Industry Information and Updates: ET HealthWorld : ETHealthworld.com
» Zydus Life gets final USFDA approval to manufacture, market ulcer drug
https://ift.tt/meIcNo0
No comments:
Post a Comment